MR1 and cancer: Next, we tested CD8+ T cells from Donor 216T expressing the MC.7.G5 TCR against a wider panel of MR1*01+/+ or MR1*01/*02 cancer cells (Figure 2F and Supplemental Figure 5, E and F).